Glucose monitoring and glucose lowering agents for children and young people with type 2 diabetes: summary of updated NICE guidance

BMJ. 2023 Sep 12:382:1686. doi: 10.1136/bmj.p1686.

Authors

Linyun Fou¹, Juliana Chizo Agwu², Nivedita Aswani³, Chirag Bakhai⁴, Evelien Gevers^{5

6}

Affiliations

¹ National Institute for Health and Care Excellence (NICE), Manchester, UK.
² Paediatrics, Sandwell & West Birmingham NHS Trust.
³ Sheffield Children's Hospital NHS Foundation Trust, Sheffield.
⁴ Larkside Practice, Luton.
⁵ Barts Health NHS Trust, Royal London Children's Hospital, London.
⁶ Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London.

PMID: 37699608
DOI: 10.1136/bmj.p1686

No abstract available

MeSH terms

Adolescent
Blood Glucose
Blood Glucose Self-Monitoring
Child
Diabetes Mellitus, Type 2* / drug therapy
Hematologic Tests
Humans

Substances

Blood Glucose